Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Cash from Financing Activities (2010 - 2025)

Siga Technologies' (SIGA) quarterly Cash from Financing Activities came in at -$403480.0 in Q3 2025, down 47.18% on a YoY basis from -$763943.4 in Q3 2024, and up 99.06% quarter-over-quarter from -$42.9 million in Q2 2025.

Analysis

Siga Technologies (SIGA) Cash from Financing Activities (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Cash from Financing Activities for 16 consecutive years, with -$403480.0 the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities fell 47.18% year-over-year to -$403480.0; the trailing twelve-month figure through Sep 2025 stood at -$43.6 million (down 0.74% YoY), and the FY2024 full-year result was -$43.5 million, changed 0.1% from the prior year.
  • Cash from Financing Activities grew to -$403480.0 in Q3 2025 per SIGA's latest filing, from -$42.9 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at -$158980.0 in Q1 2024 and bottomed at -$42.9 million in Q2 2025.
  • Historically, Cash from Financing Activities has averaged -$12.7 million across 5 years, with a median of -$6.6 million in 2021.
  • The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities plunged 453.31% in 2022, then surged 97.9% in 2024.
  • Over 5 years, Cash from Financing Activities stood at -$5.8 million in 2021, then soared by 50.45% to -$2.9 million in 2022, then plunged by 1157.24% to -$35.9 million in 2023, then jumped by 99.55% to -$161756.0 in 2024, then slumped by 149.44% to -$403480.0 in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered -$403480.0, -$42.9 million, and -$166193.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn -8.78 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn -5.05 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -2.02 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -3.66 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -2.10 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn - 2.42 Bn
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 65.46 Mn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn 122.40 Mn
10 Siga Technologies 235.60 Mn 80.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -403,480.00
Jun 30, 2025 -42.89 Mn
Mar 31, 2025 -166,193.00
Dec 31, 2024 -161,756.00
Sep 30, 2024 -274,132.00
Jun 30, 2024 -42.87 Mn
Mar 31, 2024 -158,980.00
Jun 30, 2023 -35.87 Mn
Mar 31, 2023 -7.56 Mn
Dec 31, 2022 -2.85 Mn
Jun 30, 2022 -36.52 Mn
Mar 31, 2022 -6.59 Mn
Dec 31, 2021 -5.76 Mn
Sep 30, 2021 -7.30 Mn
Jun 30, 2021 -6.60 Mn
Mar 31, 2021 -6.54 Mn
Dec 31, 2020 -6.72 Mn
Sep 30, 2020 -5.74 Mn
Jun 30, 2020 -15.22 Mn
Mar 31, 2020 -86.92 Mn